Generation of a TP53-modified porcine cancer model by CRISPR/Cas9-mediated gene modification in porcine zygotes via electroporation
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
TP53 (which encodes p53) is one of the most frequently mutated genes in cancers. In this study, we generated TP53-mutant pigs by gene editing via electroporation of the Cas9 protein (GEEP), a process that involves introducing the Cas9 protein and single-guide RNA (sgRNA) targeting exon 3 and intron 4 of TP53 into in vitro-fertilized zygotes. Zygotes modified by the sgRNAs were transferred to recipients, two of which gave birth to a total of 11 piglets. Of those 11 piglets, 9 survived. Molecular genetic analysis confirmed that 6 of 9 live piglets carried mutations in TP53, including 2 piglets with no wild-type (WT) sequences and 4 genetically mosaic piglets with WT sequences. One mosaic piglet had 142 and 151 bp deletions caused by a combination of the two sgRNAs. These piglets were continually monitored for 16 months and three of the genome-edited pigs (50%) exhibited various tumor phenotypes that we presumed were caused by TP53 mutations. Two mutant pigs with no WT sequences developed mandibular osteosarcoma and nephroblastoma. The mosaic pig with a deletion between targeting sites of two sgRNAs exhibited malignant fibrous histiocytoma. Tumor phenotypes of TP53 mosaic mutant pigs have not been previously reported. Our results indicated that the mutations caused by gene editing successfully induced tumor phenotypes in both TP53 mosaic- and bi-allelic mutant pigs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Although this method is a primary method of Cas9-sgRNA delivery to cells ex vivo, electroporation has also been used successfully for Cas9 delivery to animal zygotes 82,83 , and to introduce CRISPR-Cas constructs directly into mouse skeletal muscle, resulting in restoration of dystrophin gene expression 84 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [82]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Easy quantitative assessment of genome editing by sequence trace decomposition
Brinkman, E. K., Chen, T., Amendola, M., & van Steensel, B. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku936 · Cited by 2,390
The first 30 years of p53: growing ever more complex.
Levine, A. J., & Oren, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2723 · Cited by 1,967
Pig Cloning by Microinjection of Fetal Fibroblast Nuclei
Onishi, A., Iwamoto, M., Akita, T., Mikawa, S., Takeda, K., Awata, T., Hanada, H., & Perry, A. C. F. (2000) · Science · doi:10.1126/science.289.5482.1188 · Cited by 839
Forbes, S. A., Tang, G., Bindal, N., Bamford, S., Dawson, E., Cole, C., Kok, C. Y., Jia, M., Ewing, R., Menzies, A., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp995 · Cited by 573
Advances in Swine Biomedical Model Genomics
Lunney, J. K. (2007) · International Journal of Biological Sciences · doi:10.7150/ijbs.3.179 · Cited by 513
Malkin, D. (2011) · Genes & Cancer · doi:10.1177/1947601911413466 · Cited by 508
Whitworth, K. M., Lee, K., Benne, J. A., Beaton, B. P., Spate, L. D., Murphy, S. L., Samuel, M. S., Mao, J., O'Gorman, C., Walters, E. M., et al. (2014) · Biology of Reproduction · doi:10.1095/biolreprod.114.121723 · Cited by 354
Efficient nonmeiotic allele introgression in livestock using custom endonucleases
Tan, W., Carlson, D. F., Lancto, C. A., Garbe, J. R., Webster, D. A., Hackett, P. B., & Fahrenkrug, S. C. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310478110 · Cited by 278
Cited by
The promise and challenge of therapeutic genome editing
Doudna, J. A. (2020) · Nature · doi:10.1038/s41586-020-1978-5 · Cited by 1,126
CRISPR in livestock: From editing to printing
Menchaca, A., dos Santos-Neto, P. C., Mulet, A. P., & Crispo, M. (2020) · Theriogenology · doi:10.1016/j.theriogenology.2020.01.063 · Cited by 104
Gene transfer to plants by electroporation: methods and applications
Özyiğit, İ. İ. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05343-4 · Cited by 95
Improvements in Gene Editing Technology Boost Its Applications in Livestock
Périssé, I. V., Fan, Z., Singina, G. N., White, K. L., & Polejaeva, I. A. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2020.614688 · Cited by 96
Genome editing approaches to augment livestock breeding programs
Bishop, T., & Eenennaam, A. L. V. (2020) · Journal of Experimental Biology · doi:10.1242/jeb.207159 · Cited by 85
Metadata
- Authors
- Tanihara, F., Hirata, M., Nguyen, N. T., Le, Q. A., Hirano, T., Takemoto, T., Nakai, M., Fuchimoto, D.-I., & Otoi, T.
- Affiliations
- Tokushima University (JP)
- Institute of Advanced Medical Sciences, Tokushima University (JP)
- National Agriculture and Food Research Organization (JP)
- Corresponding author
- Tanihara, Fuminori
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2018-10-23
- Volume
- 13
- Issue
- 10
- Pages
- e0206360
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC6198999
- OpenAlex
- W2896848238
- Cited by
- 63
- References
- 39
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 6 · 2023: 6 · 2022: 8 · 2021: 15 · 2020: 12 · 2019: 6
- FWCI
- 2.94
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (publishedVersion, other-oa)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- U.S. Department of Agriculture (2015-33522-24106, 2017-38420-26790)
- Nihon University
- Ministry of Education, Culture, Sports, Science and Technology
- National Institutes of Health
- Division of Agriculture and Natural Resources, University of California
- University of California, Davis
- Japan Society for the Promotion of Science (17H03607, 18KT0024, 17H03938, 17K19325)
- Genome Center, University of California, Davis (1S10OD010786-01)
- Science and Technology Research Partnership for Sustainable Development
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
- Health Sciences › Medicine › Surgery › Xenotransplantation and immune response
- Keywords
- TP53 mutation, p53, CRISPR/Cas9 genome editing, somatic mosaicism, osteosarcoma, Wilms tumor, malignant fibrous histiocytoma, tumor phenotype, single guide RNA
- MeSH terms
- Gene Editing, Animals, Disease Models, Animal, Genotype, Neoplasms, Phenotype, Swine, Zygote, Tumor Suppressor Protein p53, Gene Deletion, Histiocytoma, Benign Fibrous, Electroporation, Animals, Genetically Modified, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Generation of a TP53-modified porcine cancer model by CRISPR/Cas9-mediated gene modification in porcine zygotes via electroporation. https://app.cochat.ai/papers/10.1371/journal.pone.0206360
- The paper
- Tanihara, F., Hirata, M., Nguyen, N. T., Le, Q. A., Hirano, T., Takemoto, T., Nakai, M., Fuchimoto, D.-I., & Otoi, T. (2018). Generation of a TP53-modified porcine cancer model by CRISPR/Cas9-mediated gene modification in porcine zygotes via electroporation. PLOS ONE. https://doi.org/10.1371/journal.pone.0206360
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.